Literature DB >> 21272222

Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia.

Bassel Noumi1, Sergio Teruya, Say Salomon, Stephen Helmke, Mathew S Maurer.   

Abstract

Racial differences in the prevalence of anemia in patients with heart failure have been noted. The diagnosis of anemia in heart failure patients can be confounded by many factors. Plasma volume expansion is one of the most prominent confounders. The authors investigated the difference of anemia prevalence using two different diagnostic techniques: peripheral hemoglobin recommended by the World Health Organization criteria and blood volume (BV) analysis. Racial disparities in the prevalence of anemia using both measures were compared. Sixty patients with heart failure and preserved ejection fraction (HFPEF) underwent measurement of BV by a radio-labeled albumin technique. Anemia was defined by both WHO criteria and by measured red blood cell volume (RBCV) >10% below ideal. Anemia was found in 67% of patients by the peripheral hemoglobin technique with no racial disparity. Only 35% of the patients had anemia by the BV analysis, with a 2-fold higher prevalence among Hispanics compared with whites and blacks. In patients with HFPEF, the diagnosis of anemia based on hemoglobin is confounded by plasma volume derangements resulting in significant overdiagnosis in this cohort. Racial differences in the rate of anemia were found. Such data could have important implications for the diagnosis and management of anemia in ethnic minorities with HFPEF.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272222      PMCID: PMC3777395          DOI: 10.1111/j.1751-7133.2010.00208.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  28 in total

1.  Nutritional anaemias. Report of a WHO scientific group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1968

2.  The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.

Authors:  D S Silverberg; M Blum; Z Agbaria; V Deutsch; M Irony; D Schwartz; R Baruch; T Yachnin; S Steinbruch; A Iaina
Journal:  Clin Nephrol       Date:  2001-03       Impact factor: 0.975

3.  Prevalence and mortality rate of congestive heart failure in the United States.

Authors:  D D Schocken; M I Arrieta; P E Leaverton; E A Ross
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

4.  Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

Authors:  Donna M Mancini; Stuart D Katz; Chim C Lang; John LaManca; Alhakam Hudaihed; Ana-Silvia Androne
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

5.  Hemodilution is common in patients with advanced heart failure.

Authors:  Ana-Silvia Androne; Stuart D Katz; Lars Lund; John LaManca; Alhakam Hudaihed; Katarzyna Hryniewicz; Donna M Mancini
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 6.  Anemia as a risk factor and therapeutic target in heart failure.

Authors:  G Michael Felker; Kirkwood F Adams; Wendy A Gattis; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

7.  Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes.

Authors:  Ana Silvia Androne; Katarzyna Hryniewicz; Alhakam Hudaihed; Donna Mancini; John Lamanca; Stuart D Katz
Journal:  Am J Cardiol       Date:  2004-05-15       Impact factor: 2.778

8.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia.

Authors:  Jack M Guralnik; Richard S Eisenstaedt; Luigi Ferrucci; Harvey G Klein; Richard C Woodman
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

9.  Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.

Authors:  Marc Klapholz; Matthew Maurer; April M Lowe; Frank Messineo; Jay S Meisner; Judith Mitchell; Jill Kalman; Robert A Phillips; Richard Steingart; Edward J Brown; Robert Berkowitz; Robert Moskowitz; Anita Soni; Donna Mancini; Rachel Bijou; Khashayar Sehhat; Nikita Varshneya; Marrick Kukin; Stuart D Katz; Lynn A Sleeper; Thierry H Le Jemtel
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

10.  A meta-analysis of erythropoiesis-stimulating agents in anaemic patients with chronic heart failure.

Authors:  Bo Jin; Xinping Luo; Haihong Lin; Jian Li; Haiming Shi
Journal:  Eur J Heart Fail       Date:  2009-12-22       Impact factor: 15.534

View more
  5 in total

1.  Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization: design and rationale for the Geriatric OUt of hospital Randomized MEal Trial in Heart Failure (GOURMET-HF).

Authors:  Jeffrey D Wessler; Mathew S Maurer; Scott L Hummel
Journal:  Am Heart J       Date:  2015-01-07       Impact factor: 4.749

Review 2.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Bharathi Upadhya; George E Taffet; Che Ping Cheng; Dalane W Kitzman
Journal:  J Mol Cell Cardiol       Date:  2015-03-06       Impact factor: 5.000

3.  Update on heart failure with preserved ejection fraction.

Authors:  Scott L Hummel; Dalane W Kitzman
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12

4.  Randomized supplementation of 4000 IU vitamin D3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial.

Authors:  J B Ernst; S Prokop; U Fuchs; J Dreier; J Kuhn; C Knabbe; H K Berthold; S Pilz; I Gouni-Berthold; J F Gummert; J Börgermann; A Zittermann
Journal:  Nutr J       Date:  2017-08-23       Impact factor: 3.271

5.  Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction.

Authors:  David Montero; Thomas Haider; Jens Barthelmes; Jens P Goetze; Silviya Cantatore; Isabella Sudano; Frank Ruschitzka; Andreas J Flammer
Journal:  Physiol Rep       Date:  2019-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.